1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NHS Cancer Programme: Innovation Open Call 4 is sponsored by Innovate UK (part of UK Research and Innovation). This call funds projects that implement a solution and measure its impact across several NHS sites in England, aimed either at freeing capacity on cancer pathways or at earlier detection and diagnosis. Projects under the first strand (freeing capacity) can claim 100% of costs.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the funder's official program page to help you evaluate fit faster.
SBRI Healthcare – NHS Innovation Open Calls (incl. Cancer Programme Open Call 4) — Funding Guide ← Back to the funding database All Grant Closed NHS England / Accelerated Access Collaborative (AAC) SBRI Healthcare – NHS Innovation Open Calls (incl.
Cancer Programme Open Call 4) Phase 1 £100K, Phase 2 £800K ✓ Open to single organisations only ✓ Private, public, and third sectors welcome ✓ Strong commercial strategy required ✓ Must address clinically themed NHS unmet need Apply through the SBRI Healthcare application portal, which becomes available on 14 October 2026. Submit as a single organisation based in the UK or EU, from private, public, or third sector.
Provide a strong commercial strategy as part of your application. SBRI Healthcare supports both early-stage innovations for feasibility and technology development, and more mature products through real-world NHS implementation studies. What else do you qualify for?
Filter nearly 3,000 opportunities by identity, stage, and region.
Identity Select Identity Women Black Indigenous People of Color LGBTQIA+ Youth & Students Veterans & Military Latino/Hispanic Immigrants & Refugees People with Disabilities Stage Select Stage Idea/Pre-revenue Pre-seed Seed Early Stage Growth Established Region Select Region North America Europe Africa Asia-Pacific Latin America & Caribbean Middle East Select all three to see your result. Grant Small projects: up to...
Innovate UK Biomedical Catalyst – Industry-led R&D (Small... Innovate UK / UK Research and Innovation... Grant Typically €1.
5M–€10M per... Horizon Europe – Cluster 1 'Health' (2026–2027 Work... European Commission / HaDEA Grant Up to £500k (small...
Biomedical Catalyst 2025: Industry-led R&D (Small & Large... This is 1 of nearly 3,000 opportunities. This is 1 of nearly 3,000 opportunities.
$50B+ in available capital across grants, VC funds, CDFIs, and accelerators. Filter by your industry, stage, and region, and see everything you qualify for. Explore the funding database → $19/month · cancel anytime
According to the current listing, eligibility includes: Single organisations based in UK or EU from private, public or third sector. Confirm the full requirements in the official notice before applying.
The current listing shows up to £800K. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for NHS Cancer Programme: Innovation Open Call 4 are due December 1, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NHS Cancer Programme: Innovation Open Call 4 is funded by Innovate UK (part of UK Research and Innovation). Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
LSC opened its 2027 Pro Bono Innovation Fund with Jan. 13 pre-applications, a new scholarship track and no Incubation lane, while a House bill would halve LSC.
Read articleDFOP0020010 is a $50 million Annual Program Statement from the U.S. Embassy in Amman. It funds 3 to 5 awards of $2 million to $20 million for U.S.-Jordanian joint ventures, cross-border investment, and U.S. exports, and for-profit companies are eligible. Statements of interest are three pages, reviewed quarterly, and accepted November 1, 2026 through September 30, 2027. Here is how the program works, what reviewers score, and why applying early matters.
Read articleThe U.S. Small Business Growth and Innovation Program closes October 21, 2026 at 12:00 PM PT with $2 million in grants of $100,000 to $250,000. Eligibility requires an annual operating budget between $1 million and $10 million — a two-sided gate that excludes the neighborhood provider and the national intermediary alike.
Read article